Joe Betts-LaCroix, Retro Biosciences | theCUBE + NYSE Wired: MedTech Unplugged Series
Show Notes
In this episode of the MedTech Unplugged Series, Joe Betts-LaCroix, CEO of Retro Biosciences, discusses the company's goal of extending the healthy human lifespan by a decade. Backed by prominent figures like Sam Altman, Retro Biosciences is focused on translating academic research in aging biology into practical therapeutics to combat age-related diseases, which make up a significant portion of current healthcare expenditures. Betts-LaCroix emphasizes the transformative role of artificial intelligence (AI) in personalized medicine and the need for agile learning to keep pace with rapid technological advancements in the medtech field. The conversation, hosted by John Furrier, explores the complexities of moving from academic theory to real-world application and highlights the imperative of collaborating with data to drive breakthroughs.
Key Topics Covered:- Mission of Retro Biosciences to extend healthy human lifespan.
- Significance of age-related diseases in healthcare costs.
- The role of AI in personalizing medicine and therapeutic development.
- Transition from academic research in aging biology to commercial applications.
- Importance of computational models and large-scale systems in advancing scientific discovery.
- Mindset shifts necessary for practitioners in the evolving medtech landscape.
- Strategies for training the next generation of biologically-focused professionals.
- The challenges and potential of cell replacement therapies in addressing aging.